Global Economic Burden of Attention-Deficit/Hyperactivity Disorder: A Systematic Review.
Anindit ChhibberAlexandre Hikiji WatanabeChayutthaphong ChaisaiSajesh K VeettilNathorn ChaiyakunaprukPublished in: PharmacoEconomics (2021)
Despite the wide variation in methodologies in studies reviewed, the literature suggests that ADHD imposes a substantial economic burden on society. There is a dire need for cost-of-illness research in low- and middle-income countries to better inform the treatment and management of ADHD in these countries. In addition, guidelines on the conduct and reporting of economic burden studies are needed as they may improve standardisation of cost-of-illness studies.